Gutierrez Absalon
Assistant Professor of Medicine
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (3)
Year:
2026
While the earliest pathological signs of cardiovascular disease (CVD) emerge before age 20, current adult-based risk thresholds fail to identify a substantial fraction of high-risk children. With the rising prevalence of childhood obesity, the need for early and sensitive detection of cardiovascular-kidney-metabolic disease (CKMD) risk is paramount to enable timely intervention that can prevent the trajectory toward CVD in later life. To identify early accessible molecular biomarkers of CKMD in children, we measured 25 CKMD phenotypes, spanning liver, adipose, vascular, and dysglycemia traits, linked those to the circulating proteome and built a multi-protein signature of composite CKMD, leveraging data from 273 children and adolescents (13.1 ± 2.7 years; 53% females). We compared these results to the adult CKMD proteome, using data from 685 adults from the same community and 28,257 adults from the UK Biobank. The pediatric CKMD proteome was highly concordant with the adult CKMD proteome, reflecting known and novel mechanisms of pancreatic beta-cell health and insulin sensitivity, liver homeostasis, inflammation, and cholesterol metabolism. Similarly, multi-protein signatures of composite CKMD phenotypes in children were strongly associated with CKMD-related outcomes in both adult populations. Importantly, many proteins linked to pediatric CKMD were modifiable with GLP-1 receptor agonist therapy, associated with adult CKMD-related outcomes in a large-scale proteome-wide association study (PWAS), and exhibited significant variability during development (ages 4-24 years). These findings demonstrate that CKMD develops starting early in life-course continuum, with proteomic profiles linked to future irreversible CVD conditions emerging early in life when they may still be reversible. This highlights a critical opportunity to improve CVD-free longevity through precision medicine diagnosis and intervention in children and adolescents.
Year:
2025
Background Severe obesity (SevO; BMI ≥40 kg/m²) is rapidly increasing globally and disproportionately affects minority populations. However, it remains understudied in mechanistic and omics literature. Lipid metabolism plays a central role in obesity-related cardiometabolic disease (CMD), but the relationship between molecular lipid species and SevO is poorly understood, particularly in high-risk groups. Methods We analyzed 578 participants from the Cameron County Hispanic Cohort (CCHC) with fasting plasma lipidomic and genetic data, comparing those living with SevO (n=185) to non-obese controls (n=393). A total of 830 circulating lipid species across 49 classes were quantified. Associations between individual lipids and SevO were assessed using logistic regression and orthogonal projections to latent structures discriminant analysis (OPLS-DA). Potential causal links were assessed using network deconvolution mendelian randomization (NDMR), and influential lipids were correlated with CMD traits and DXA-derived body composition. Results Participants with SevO exhibited statistically significantly more adverse cardiometabolic risk factors than controls. Lipidomic profiling revealed broad alterations: shorter, saturated, and monounsaturated triacylglycerols were markedly elevated, while lysophospholipids, plasmalogens, cholesteryl esters, and long-chain lipids were reduced in individuals with SevO when compared to controls (BMI ≥ 18.5 and > 25 kg/m²). OPLS-DA identified over 300 influential lipid species predictive of SevO status. NDMR analyses implicated specific triacylglycerol species as potentially causally linked with SevO status. Influential lipids correlated with insulin resistance, liver steatosis, body fat measures, and HDL-C (absolute value ranges 0.2-0.4). Conclusions Our findings reveal that SevO is marked by extensive and lipid class-specific dysregulation of the circulating lipidome, with strong links to cardiometabolic risk. Notably, triacylglycerols containing shorter length acyl chains emerged as a distinctive lipid signature of SevO—consistently elevated, strongly discriminative of SevO status, and uniquely exhibiting a consistent causal relationship. Our results provide compelling evidence for a novel lipidomic pathway underpinning severe obesity and underscore critical avenues for future research into its genetic, dietary, and mechanistic determinants.
Year:
2025
Collaborators (22)
Joseph McCormick
James H. Steele Professor
-
Jean W. Hsu
Baylor College of Medicine
Lindsay Fernandez-Rhodes
Associate Professor
Pennsylvania State University
Andrew S. Perry
Vanderbilt University Medical Center
Shilin Zhao
Vanderbilt University Medical Center
Miryoung Lee
Associate Professor
The University of Texas Health Science Center at Houston
Mohammad Yaser Anwar
Tenure-track Assistant Professor
The University of Texas Health Science Center at Houston
John Blangero
Professor/Director Genomics Computing Center
University of Texas Rio Grande Valley School of Medicine
Heather M Highland
University of North Carolina at Chapel Hill
Quinn Wells
Associate Professor of Medicine
Vanderbilt University Medical Center
Eric Farber-Eger
Vanderbilt University Medical Center
Ruchi Gaba
Baylor College of Medicine
Kari North
Professor
University of North Carolina at Chapel Hill
Eric Gamazon
University of Chicago
Joanne Curran
Professor
The University of Texas Rio Grande Valley
Mariaelisa Graff
Assistant Professor
University of North Carolina
Daeeun Kim
Research Professor
Seoul National University Hospital
Peter Meikle
Head
Baker Heart and Diabetes Institute
Matthew Nayor
Boston University School of Medicine
Quanhu Sheng
Associate Professor
Vanderbilt University Medical Center
Penny Gordon-Larsen
Vice Chancellor for Research and William R. Kenan, Jr. Distinguished Professor, Nutrition
University of North Carolina at Chapel Hill
Corey Giles
Laboratory Head
Baker Heart and Diabetes Institute
Make your next move.
Prepare your application
Review drafts before you send them.